AcelRx Pharmaceuticals Performance

ACRXDelisted Stock  USD 0.86  0.08  10.26%   
AcelRx Pharmaceuticals holds a performance score of 61 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.84, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AcelRx Pharmaceuticals will likely underperform. Use AcelRx Pharmaceuticals jensen alpha and the relationship between the potential upside and price action indicator , to analyze future returns on AcelRx Pharmaceuticals.

Risk-Adjusted Performance

61 of 100

 
Low
 
High
Market Crasher
Compared to the overall equity markets, risk-adjusted returns on investments in AcelRx Pharmaceuticals are ranked lower than 61 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, AcelRx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow12.7 M
  

AcelRx Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  74.00  in AcelRx Pharmaceuticals on December 30, 2023 and sell it today you would earn a total of  12.00  from holding AcelRx Pharmaceuticals or generate 16.22% return on investment over 90 days. AcelRx Pharmaceuticals is currently generating 2.2024% in daily expected returns and assumes 2.7986% risk (volatility on return distribution) over the 90 days horizon. In different words, 24% of stocks are less volatile than AcelRx, and 57% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days AcelRx Pharmaceuticals is expected to generate 4.88 times more return on investment than the market. However, the company is 4.88 times more volatile than its market benchmark. It trades about 0.79 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.24 per unit of risk.

AcelRx Pharmaceuticals Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for AcelRx Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AcelRx Pharmaceuticals, and traders can use it to determine the average amount a AcelRx Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.787

Best PortfolioBest Equity
Good Returns
Average ReturnsACRX
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.8
  actual daily
24
76% of assets are more volatile

Expected Return

 2.2
  actual daily
43
57% of assets have higher returns

Risk-Adjusted Return

 0.79
  actual daily
61
61% of assets perform worse
Based on monthly moving average AcelRx Pharmaceuticals is performing at about 61% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AcelRx Pharmaceuticals by adding it to a well-diversified portfolio.

AcelRx Pharmaceuticals Fundamentals Growth

AcelRx Stock prices reflect investors' perceptions of the future prospects and financial health of AcelRx Pharmaceuticals, and AcelRx Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AcelRx Stock performance.

About AcelRx Pharmaceuticals Performance

To evaluate AcelRx Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when AcelRx Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare AcelRx Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand AcelRx Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents AcelRx's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California. Acelrx Pharmaceutica operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.

Things to note about AcelRx Pharmaceuticals performance evaluation

Checking the ongoing alerts about AcelRx Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AcelRx Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
AcelRx Pharmaceuticals is now traded under the symbol TLPH. Please update your portfolios or report it if you believe this is an error. Report It!
AcelRx Pharmaceuticals is not yet fully synchronised with the market data
AcelRx Pharmaceuticals has some characteristics of a very speculative penny stock
AcelRx Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
AcelRx is showing solid risk-adjusted performance over 90 days
AcelRx Pharmaceuticals currently holds about 22.92 M in cash with (28.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Evaluating AcelRx Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate AcelRx Pharmaceuticals' stock performance include:
  • Analyzing AcelRx Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AcelRx Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining AcelRx Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating AcelRx Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of AcelRx Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of AcelRx Pharmaceuticals' stock. These opinions can provide insight into AcelRx Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating AcelRx Pharmaceuticals' stock performance is not an exact science, and many factors can impact AcelRx Pharmaceuticals' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in AcelRx Stock

If you are still planning to invest in AcelRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AcelRx Pharmaceuticals' history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Correlations
Find global opportunities by holding instruments from different markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities